← 홈

Antibody

1,830개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-11 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,830개
AntibodystaleLei LiuPhase 2

MRG003 combined with Pucotenlimab (MRG003 combined with Pucotenlimab)

Head and Neck Squamous Cell Carcinoma (HNSCC) · Head and Neck Squamous Cell Carcinoma (H

#HeadandNeckSquamousCellCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleLei LiuPhase 2

MRG003 combined with Pucotenlimab+Cisplatin (MRG003 combined with Pucotenlimab+Cisplatin)

Head and Neck Squamous Cell Carcinoma (HNSCC) · Head and Neck Squamous Cell Carcinoma (H

#HeadandNeckSquamousCellCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleMyeloid TherapeuticsPhase 1

atezolizumab (Tecentriq, MT-303 +Atezolizumab + Bevacizumab)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystalePresage BiosciencesPhase 1

nivolumab (Opdivo, MVC-101 + Nivolumab)

Solid Tumour · Solid Tumour

#SolidTumour#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodyBiologicstaleTongji HospitalPreclinical

Mab Therapy (Mab Therapy)

NMO Spectrum Disorder · NMO Spectrum Disorder

#NMOSpectrumDisorder#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleInstitute for Clinical and Expe…Preclinical

MabCampath, (MabCampath,)

Kidney Transplantation · Kidney Transplantation

#KidneyTransplantation#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleCentre Hospitalier Departementa…Phase 3

Maintenance (Maintenance, Maintenance (or initiation) of immunosuppressive treatment: Imurel®, Mabthera®,Cellcept®, Cortancyl®, or initiation)

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; End Stage Renal Disease · Anti-Neutrophil Cytoplasmic Antibody-Ass

#Anti-NeutrophilCytoplasmicAntibo#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystalePfizerPhase 1

Maplirpacept (Maplirpacept)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystalePfizerPhase 1

PF-07901801 (Maplirpacept, Maplirpacept (PF-07901801))

Lymphoma; Multiple Myeloma · Lymphoma

#Lymphoma#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 2

Melphalan/HDS Followed by Consolidation Treatment with Trifluridine-tipiracil plus Bevacizumab (Melphalan/HDS Followed by Consolidation Treatment with Trifluridine-tipiracil plus Bevacizumab)

Refractory Metastatic Colorectal Cancer · FRα

#FR#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleGenentech, Inc.Phase 1

MetMAb (MetMAb)

Solid Cancers · Solid Cancers

#SolidCancers#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleUniversité Catholique de LouvainApproved

Methotrexate + Infliximab (Methotrexate + Infliximab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAustralasian Gastro-Intestinal …Phase 3

Mitomycin C; Capecitabine; Bevacizumab (Mitomycin C; Capecitabine; Bevacizumab)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 2

daratumumab (Darzalex, Mitoxantrone hydrochloride liposome/Dexamethasone/daratumumab)

Relapsed/Refractory Multiple Myeloma · FRα

#FR#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleNYU Langone HealthPhase 1

nivolumab (Opdivo, Mocetinostat Induction Phase + Ipilimumab + Nivolumab)

Melanoma · Melanoma

#Melanoma#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleNYU Langone HealthPhase 1

nivolumab (Opdivo, Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab)

Melanoma · Melanoma

#Melanoma#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleAssistance Publique Hopitaux De…Phase 2

IPH2201 (Monalizumab, Monalizumab (IPH2201))

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleIstituto Clinico HumanitasPhase 2

anti-NKG2A monoclonal antibody (Monalizumab, Monalizumab (anti-NKG2A monoclonal antibody))

Acute Myeloid Leukaemia; MDS (Myelodysplastic Syndrome) · Acute Myeloid Leukaemia

#AcuteMyeloidLeukaemia#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodyBiologicstaleSWISS BIOPHARMA MED GmbHPhase 1

Monoclonal antibody (Mab, Monoclonal antibody, Monoclonal antibody (Mab) sB24M)

Pyoderma; Pyoderma Gangrenosum · Pyoderma

#Pyoderma#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystalePresage BiosciencesPhase 1

nivolumab (Opdivo, Motolimod + Nivolumab)

HNSCC · HNSCC

#HNSCC#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 DISCONTINUED

56 / 92 페이지

← 이전다음 →